A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced U.S. Food and Drug Administration (FDA) clearance of EndeavorOTC Ⓡ (AKL-T01) as an over-the ...

Akili Interactive Labs, a digital therapeutics company that’s developed a video game to improve attention deficit hyperactivity disorder, has closed a $55 million Series C round financing. The fresh ...

BOSTON--(BUSINESS WIRE)--Akili Interactive (“Akili” or the “Company”), a leading digital medicine company developing cognitive treatments through game-changing technologies, today announced the ...

Akili (NASDAQ:AKLI) stock rose ~38% on Wednesday after the company reported results from a trial of video game-based therapy EndeavorRx to treat adults with attention ...

Akili today announced the official release of its new product, EndeavorOTC. The mobile game is a version of Akili’s similarly named, FDA-authorized EndeavorRX, built upon the same technology. But ...

After getting FDA clearance for its game to improve attention in kids with ADHD, digital health company Akili Interactive is looking to bring another to the market. The Boston-based company struck a ...